-+ 0.00%
-+ 0.00%
-+ 0.00%

Addicon Holdings (09860) terminates acquisition of 100% of Crown Bioscience International's shares

Zhitongcaijing·11/16/2026 04:57:06
Listen to the news

According to Zhitong Finance App, Adicon Holdings (09860) issued an announcement relating to (including) the proposed acquisition of 100% of the issued shares of Crown Bioscience International (target company) (acquisition).

Since regulatory approval was not obtained on or before the termination date, the buyer and seller jointly agreed to terminate the share purchase agreement on November 13, 2026 (after the trading period), with immediate effect (termination). Therefore, the acquisition will not be carried out, and after termination, the Company will not publish or send any circular to shareholders regarding the acquisition.

After the termination takes effect, the terms of the share purchase agreement (other than those that clearly state that it will continue after its termination) no longer have any effect or effect, and the buyer, seller, or target company no longer assumes any further obligation or liability to each other as a result.

The Board believes that the termination will not have any significant adverse impact on the Group's business operations or financial position.